Carisoprodol
- Product NDC
- 71610-430
- 11-digit product format
- 716100430
- Labeler code
- 71610
- Product ID
- 71610-430_e80c2151-5bcf-454b-b0ee-94beb3fbb40d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carisoprodol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA040245
- Marketing category
- ANDA
- Marketing start
- 2019-08-08
- Marketing end
- 0000-00-00
- Substance
- CARISOPRODOL
- Active strength
- 350 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-430 | CARISOPRODOL TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20200613_df717e2c-514a-423f-aef3-a9bf25619efa.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-430-30 | 71610043030 | 30 TABLET in 1 BOTTLE (71610-430-30) | 30 tablet | 2020-06-03 | 0000-00-00 | No | No | Current |
| 71610-430-53 | 71610043053 | 60 TABLET in 1 BOTTLE (71610-430-53) | 60 tablet | 2020-06-03 | 0000-00-00 | No | No | Current |
| 71610-430-60 | 71610043060 | 90 TABLET in 1 BOTTLE (71610-430-60) | 90 tablet | 2020-06-03 | 0000-00-00 | No | No | Current |
| 71610-430-70 | 71610043070 | 120 TABLET in 1 BOTTLE (71610-430-70) | 120 tablet | 2020-06-03 | 0000-00-00 | No | No | Current |